Association of ERCC1 and XPF polymorphisms with pediatric glioma susceptibility

Yongping Chen,Yuxiang Liao,Xingyu Jia,Huiran Lin,Lei Miao,Li Yuan,Xiaokai Huang,Jingying Zhou,Jun Bian,Zhenjian Zhuo
DOI: https://doi.org/10.1097/cm9.0000000000002126
IF: 6.133
2023-04-21
Chinese Medical Journal
Abstract:To the Editor: Glioma is a highly invasive and lethal heterogeneous disease caused by glial or precursor cell mutation. It accounts for about 50% of tumors in children and 80% of malignant tumors. [1] The nucleotide excision repair (NER) pathway is a process that involves the sequential assembly of many proteins, including excision repair cross complementation group 1 (ERCC1) and xeroderma pigmentosum complementation group F (XPF, also known as ERCC4). They play key roles in repairing DNA damages caused by ultraviolet light and helixdistorting adducts. The ERCC1–XPF forms a dimer to produce a multifunctional endonuclease essential for DNA repair. [2] Without DNA repair, DNA lesions aggregate and develop into glioma. The single nucleotide polymorphisms (SNPs) of genes involved in the DNA repair pathway may be potential targets for altering the risk of glioma. At present, the relationship between polymorphisms of these two genes and glioma has rarely been described.
medicine, general & internal
What problem does this paper attempt to address?